Get started
Author

Luca Mancinelli

Predictors and dynamics of postpartum relapses in women with multiple sclerosis
2013 · Stella E Hughes, Tim Spelman, et al. · Multiple Sclerosis Journal · 194
A systematic review of neurological manifestations of SARS‐CoV‐2 infection: the devil is hidden in the details
2020 · M. Romoli, I. Jelcic, et al. · European Journal of Neurology · 112
PDF
Sleep-related disorders and their relationship with MRI findings in multiple sclerosis
2019 · M. Foschi, G. Rizzo, et al. · Sleep Medicine · 89
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context
2021 · Maria Pia Sormani, Irene Schiavetti, et al. · Neurology Neuroimmunology & Neuroinflammation · 76
PDF
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis
2023 · Tomas Kalincik, Sifat Sharmin, et al. · JAMA Neurology · 68
PDF
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study
2018 · Luca Prosperini, Pietro Annovazzi, et al. · Journal of Neurology · 59
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis
2024 · Elisabetta Maida, Marcello Moccia, et al. · Journal of Neurology · 55
PDF
Multiple Sclerosis Progression and Relapse Activity in Children
2023 · Pietro Iaffaldano, Emilio Portaccio, et al. · JAMA Neurology · 55
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study
2021 · Maria Pia Sormani, Irene Schiavetti, et al. · Multiple Sclerosis Journal · 49
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing–remitting multiple sclerosis
2014 · Tomas Kalincik, Vilija Jokubaitis, et al. · Multiple Sclerosis Journal · 41
Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS
2016 · Tim Spelman, Tomas Kalincik, et al. · Neurology Clinical Practice · 37
PDF
Frequency and characteristics of dysautonomic symptoms in multiple sclerosis: a cross-sectional double-center study with the validated Italian version of the Composite Autonomic Symptom Score-31
2020 · Matteo Foschi, Giulia Giannini, et al. · Neurological Sciences · 26
PDF
Hypogammaglobulinemia and severe infections in Multiple Sclerosis patients on anti-CD20 agents: A multicentre study
2024 · K. Smolik, F. Camilli, et al. · Multiple Sclerosis and Related Disorders · 19
PDF
Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register
2023 · Paola Mosconi, Tommaso Guerra, et al. · Neurological Sciences · 14
PDF
Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect Relationship
2018 · Manuela Contin, Luca Mancinelli, et al. · Clinical Neuropharmacology · 12
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy
2021 · Elisa Baldin, Corrado Zenesini, et al. · Neuroepidemiology · 9
“Nail loss after teriflunomide treatment: A new potential adverse event”
2017 · L. Mancinelli, P. Amerio, et al. · Multiple Sclerosis and Related Disorders · 8
Sex differences in relapse-independent and relapse-associated disability progression in relapsing-remitting multiple sclerosis: a real-world inverse-probability weighted study
2025 · Matteo Foschi, Damiano Marastoni, et al. · Therapeutic Advances in Neurological Disorders · 7
Teeth loss after teriflunomide treatment: Casual or causal? A short case series
2018 · Veria Vacchiano, Nicola Frattaruolo, et al. · Multiple Sclerosis and Related Disorders · 7
Do patients’ and referral centers’ characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register
2022 · Roberto Bergamaschi, Ettore Beghi, et al. · Neurological Sciences · 5
PDF
Late-onset multiple sclerosis is associated with relapse-independent disability accrual: a propensity score-weighted recurrent-event study
2026 · Andrea Surcinelli, Ivan Panzera, et al. · Journal of Neurology · 3
Ofatumumab Versus Intravenous Ocrelizumab after Sphingosine-1-Phosphate Receptor Modulators in Patients with Relapsing–Remitting Multiple Sclerosis: A Real-World Inverse Probability of Treatment Weighting Multicenter Study
2026 · Gianmarco Abbadessa, Damiano Marastoni, et al. · CNS Drugs · 2
Harmonized magnetic resonance imaging protocols for multiple sclerosis: HARMONY-MS, a pilot project
2025 · Andrea Surcinelli, Ilaria Massa, et al. · Journal of Neurology · 2
Fulminant case of multiple sclerosis (marburg variant) with atypical MRI presentation
2021 · Luca Mancinelli, Yerma Bartolini, et al. · Journal of Clinical Images and Medical Case Reports · 2
PDF
Holmes‐Like Tremor in Ataxia With Oculomotor Apraxia Type 2
2014 · Maria Chiara D'Amico, Iole Borrelli, et al. · Movement Disorders Clinical Practice · 2
PDF
Works count: 38
Citation count: 954
H-index: 14
I10-index: 15
Year
Topic
Type